Cargando…

Pharmacogenetics of the Central Nervous System—Toxicity and Relapse Affecting the CNS in Pediatric Acute Lymphoblastic Leukemia

SIMPLE SUMMARY: Despite recent improvements in cure rates, pediatric acute lymphoblastic leukemia (ALL) patients remain at risk to develop relapse disease or suffer from therapy-associated side effects. Over 5% of adverse events appear in the central nervous system (CNS) and can impact survival or q...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sági, Judit C., Gézsi, András, Egyed, Bálint, Jakab, Zsuzsanna, Benedek, Noémi, Attarbaschi, Andishe, Köhrer, Stefan, Sipek, Jakub, Winkowska, Lucie, Zaliova, Marketa, Anastasopoulou, Stavroula, Wolthers, Benjamin Ole, Ranta, Susanna, Szalai, Csaba, Kovács, Gábor T., Semsei, Ágnes F., Erdélyi, Dániel J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151239/ https://www.ncbi.nlm.nih.gov/pubmed/34066083 http://dx.doi.org/10.3390/cancers13102333

Ejemplares similares

MicroRNA-181a as novel liquid biopsy marker of central nervous system involvement in pediatric acute lymphoblastic leukemia
por: Egyed, Bálint, et al.
Publicado: (2020)

Circulating microRNAs as minimal residual disease biomarkers in childhood acute lymphoblastic leukemia
por: Rzepiel, Andrea, et al.
Publicado: (2019)

Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma
por: Hegyi, Marta, et al.
Publicado: (2016)

Subgroups of Paediatric Acute Lymphoblastic Leukaemia Might Differ Significantly in Genetic Predisposition to Asparaginase Hypersensitivity
por: Kutszegi, Nóra, et al.
Publicado: (2015)

Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma
por: Sági, Judit C., et al.
Publicado: (2018)

Co-Detection of VEGF-A and Its Regulator, microRNA-181a, May Indicate Central Nervous System Involvement in Pediatric Leukemia
por: Egyed, Bálint, et al.
Publicado: (2022)

HLA-DRB1*07:01–HLA-DQA1*02:01–HLA-DQB1*02:02 haplotype is associated with a high risk of asparaginase hypersensitivity in acute lymphoblastic leukemia
por: Kutszegi, Nóra, et al.
Publicado: (2017)

Investigation of circulating lncRNAs as potential biomarkers in chronic respiratory diseases
por: Gál, Zsófia, et al.
Publicado: (2020)

Roles of Genetic Polymorphisms in the Folate Pathway in Childhood Acute Lymphoblastic Leukemia Evaluated by Bayesian Relevance and Effect Size Analysis
por: Lautner-Csorba, Orsolya, et al.
Publicado: (2013)

Two tagging single‐nucleotide polymorphisms to capture HLA‐DRB1*07:01–DQA1*02:01–DQB1*02:02 haplotype associated with asparaginase hypersensitivity
por: Kutszegi, Nóra, et al.
Publicado: (2020)

Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance
por: Lautner-Csorba, Orsolya, et al.
Publicado: (2012)

Prevalence and characterization of severe asthma in Hungary
por: Csoma, Zsuzsanna, et al.
Publicado: (2020)

Severe asthma database in Hungary, initial steps
por: Csoma, Zsuzsanna, et al.
Publicado: (2013)

Identification of Fusion Gene Breakpoints is Feasible and Facilitates Accurate Sensitive Minimal Residual Disease Monitoring on Genomic Level in Patients With PML-RARA, CBFB-MYH11, and RUNX1-RUNX1T1
por: Lukes, Julius, et al.
Publicado: (2020)

Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of Antiretrovirals
por: Nwogu, Jacinta Nwamaka, et al.
Publicado: (2016)

Investigation of the Possible Role of the Hippo/YAP1 Pathway in Asthma and Allergy
por: Fodor, Lili E., et al.
Publicado: (2017)

Corrigendum: Investigation of the Possible Role of Tie2 Pathway and TEK Gene in Asthma and Allergic Conjunctivitis
por: Gál, Zsófia, et al.
Publicado: (2020)

Investigation of the Possible Role of Tie2 Pathway and TEK Gene in Asthma and Allergic Conjunctivitis
por: Gál, Zsófia, et al.
Publicado: (2020)

Our Experiences with Asparaginase Activity Measurements in Children with Lymphoblastic Diseases
por: Müller, Judit, et al.
Publicado: (2023)

High-efficiency pharmacogenetic ablation of oligodendrocyte progenitor cells in the adult mouse CNS
por: Xing, Yao Lulu, et al.
Publicado: (2023)

PAX5-KIAA1549L: a novel fusion gene in a case of pediatric B-cell precursor acute lymphoblastic leukemia
por: Anderl, Stefanie, et al.
Publicado: (2015)

ERG deletions in childhood acute lymphoblastic leukemia with DUX4 rearrangements are mostly polyclonal, prognostically relevant and their detection rate strongly depends on screening method sensitivity
por: Zaliova, Marketa, et al.
Publicado: (2019)

A novel class of ZNF384 aberrations in acute leukemia
por: Zaliova, Marketa, et al.
Publicado: (2021)

Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort
por: Zaliova, Marketa, et al.
Publicado: (2019)

Relapsed acute lymphoblastic leukaemia after allogeneic stem cell transplantation: a therapeutic dilemma challenging the armamentarium of immunotherapies currently available (case reports)
por: Poyer, Fiona, et al.
Publicado: (2022)

Copy Number Changes and Allele Distribution Patterns of Chromosome 21 in B Cell Precursor Acute Lymphoblastic Leukemia
por: Abbasi, M. Reza, et al.
Publicado: (2021)

Second malignant neoplasms after treatment of 1487 children and adolescents with acute lymphoblastic leukemia—A population‐based analysis of the Austrian ALL‐BFM Study Group
por: Poyer, Fiona, et al.
Publicado: (2022)

New biological and genetic classification and therapeutically relevant categories in childhood B-cell precursor acute lymphoblastic leukemia
por: Starý, Jan, et al.
Publicado: (2018)

PAX5-AUTS2: A recurrent fusion gene in childhood B-cell precursor acute lymphoblastic leukemia
por: Denk, Dagmar, et al.
Publicado: (2012)

Antibiotic prophylaxis with teicoplanin on alternate days reduces rate of viridans sepsis and febrile neutropenia in pediatric patients with acute myeloid leukemia
por: Boztug, Heidrun, et al.
Publicado: (2016)

Author Correction: Plasma neutrophil extracellular trap level is modified by disease severity and inhaled corticosteroids in chronic inflammatory lung diseases
por: Gál, Zsófia, et al.
Publicado: (2020)

Plasma neutrophil extracellular trap level is modified by disease severity and inhaled corticosteroids in chronic inflammatory lung diseases
por: Gál, Zsófia, et al.
Publicado: (2020)

VariantMetaCaller: automated fusion of variant calling pipelines for quantitative, precision-based filtering
por: Gézsi, András, et al.
Publicado: (2015)

Neuroinflammation-Driven Lymphangiogenesis in CNS Diseases
por: Hsu, Martin, et al.
Publicado: (2021)

Frequency and prognostic impact of ZEB2 H1038 and Q1072 mutations in childhood B-other acute lymphoblastic leukemia
por: Zaliova, Marketa, et al.
Publicado: (2020)

Cancer pharmacogenetics
por: Marsh, S, et al.
Publicado: (2004)

Experimental Pharmacogenetics
por: Lubs, Herbert A.
Publicado: (1964)

Pharmacogenetics of Anticoagulants
por: Rane, Anders, et al.
Publicado: (2010)

Pharmacogenetics of osteoporosis
por: Marini, Francesca, et al.
Publicado: (2010)

The pharmacogenetics of imatinib
por: Dulucq, Stéphanie, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_9gpb28ij85cuq4f8cp47skbtir